These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 1461648
1. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. Benvenisty N, Ornitz DM, Bennett GL, Sahagan BG, Kuo A, Cardiff RD, Leder P. Oncogene; 1992 Dec; 7(12):2399-405. PubMed ID: 1461648 [Abstract] [Full Text] [Related]
2. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y, Ichinohe T, Tsunetsugu-Yokota Y, Katano H, Takahashi H, Matsuda J, Sata T, Kurata T, Nagashima K, Hall WW. Nat Med; 2006 Apr; 12(4):466-72. PubMed ID: 16550188 [Abstract] [Full Text] [Related]
3. Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites. Mori N, Ueda A, Ikeda S, Yamasaki Y, Yamada Y, Tomonaga M, Morikawa S, Geleziunas R, Yoshimura T, Yamamoto N. Cancer Res; 2000 Sep 01; 60(17):4939-45. PubMed ID: 10987310 [Abstract] [Full Text] [Related]
4. A transgenic model of transactivation by the Tax protein of HTLV-I. Bieberich CJ, King CM, Tinkle BT, Jay G. Virology; 1993 Sep 01; 196(1):309-18. PubMed ID: 8356801 [Abstract] [Full Text] [Related]
5. Signaling via the CD2 receptor enhances HTLV-1 replication in T lymphocytes. Guyot DJ, Newbound GC, Lairmore MD. Virology; 1997 Jul 21; 234(1):123-9. PubMed ID: 9234953 [Abstract] [Full Text] [Related]
6. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR. Seeler JS, Muchardt C, Podar M, Gaynor RB. Virology; 1993 Oct 21; 196(2):442-50. PubMed ID: 8372429 [Abstract] [Full Text] [Related]
7. The human T cell leukemia virus type I-tax gene is responsible for the development of both inflammatory polyarthropathy resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in transgenic mice. Habu K, Nakayama-Yamada J, Asano M, Saijo S, Itagaki K, Horai R, Yamamoto H, Sekiguchi T, Nosaka T, Hatanaka M, Iwakura Y. J Immunol; 1999 Mar 01; 162(5):2956-63. PubMed ID: 10072546 [Abstract] [Full Text] [Related]
8. Molecular mechanism of tumorigenesis in mice transgenic for the human T cell leukemia virus Tax gene. Coscoy L, Gonzalez-Dunia D, Tangy F, Syan S, Brahic M, Ozden S. Virology; 1998 Sep 01; 248(2):332-41. PubMed ID: 9721242 [Abstract] [Full Text] [Related]
9. High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax. Mori N, Prager D. Cancer Res; 1996 Feb 15; 56(4):779-82. PubMed ID: 8631013 [Abstract] [Full Text] [Related]
10. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Green JE, Hinrichs SH, Vogel J, Jay G. Nature; 1989 Sep 07; 341(6237):72-4. PubMed ID: 2788824 [Abstract] [Full Text] [Related]
11. Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Nimer SD, Gasson JC, Hu K, Smalberg I, Williams JL, Chen IS, Rosenblatt JD. Oncogene; 1989 Jun 07; 4(6):671-6. PubMed ID: 2660069 [Abstract] [Full Text] [Related]
12. Suppression of the transformed phenotype in hybrids of human T-cell leukemia virus type I tax-transformed rat fibroblasts and normal human fibroblasts. Inoue H, Yamaoka S, Imamura M, Hatanaka M. Exp Cell Res; 1994 Nov 07; 215(1):68-74. PubMed ID: 7957683 [Abstract] [Full Text] [Related]
13. CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation. Grant C, Nonnemacher M, Jain P, Pandya D, Irish B, Williams SC, Wigdahl B. Virology; 2006 May 10; 348(2):354-69. PubMed ID: 16458341 [Abstract] [Full Text] [Related]
14. Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expression. Hall AP, Irvine J, Blyth K, Cameron ER, Onions DE, Campbell ME. J Pathol; 1998 Oct 10; 186(2):209-14. PubMed ID: 9924438 [Abstract] [Full Text] [Related]
15. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A, Matsuoka M. Retrovirology; 2005 Oct 22; 2():64. PubMed ID: 16242045 [Abstract] [Full Text] [Related]
16. [HTLV-I tax mediated activation of cellular genes in transgenic mice]. Shinohara T. Hokkaido Igaku Zasshi; 1991 Jul 22; 66(4):534-43. PubMed ID: 1916630 [Abstract] [Full Text] [Related]
17. [Molecular pathomechanism of HTLV-I infectious diseases]. Kitajima I. Rinsho Byori; 1997 Nov 22; 45(11):1048-56. PubMed ID: 9396344 [Abstract] [Full Text] [Related]
18. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 Tax expression. Lin HC, Hickey M, Hsu L, Medina D, Rabson AB. Virology; 2005 Aug 15; 339(1):1-11. PubMed ID: 15964046 [Abstract] [Full Text] [Related]
19. Regulation of the GATA3 promoter by human T-cell lymphotropic virus type I Tax protein. Gilli SC, Salles TS, Saad ST. J Cell Biochem; 2004 Dec 15; 93(6):1178-87. PubMed ID: 15486968 [Abstract] [Full Text] [Related]
20. [Pathological and molecular analyses of mammary tumors induced in HTLV-I pX transgenic rats]. Yamada S. Hokkaido Igaku Zasshi; 1994 May 15; 69(3):479-91, 493, 495-7. PubMed ID: 7927176 [Abstract] [Full Text] [Related] Page: [Next] [New Search]